Provention Bio Inc.

NASDAQ: PRVB · Real-Time Price · USD
24.98
0.00 (0.00%)
At close: Apr 26, 2023, 10:00 PM

Provention Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
12.89M 1.4M
Cost of Revenue
512K n/a
Gross Profit
12.38M 1.4M
Operating Income
-128.16M -115.58M
Interest Income
2.24M 146K
Pretax Income
-126.96M -115.43M
Net Income
-113.56M -114.43M
Selling & General & Admin
64.11M 47.35M
Research & Development
75.8M 69.63M
Other Expenses
627K n/a
Operating Expenses
140.54M 116.97M
Interest Expense
1.04M n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
141.06M 116.97M
Income Tax Expense
-13.39M -1M
Shares Outstanding (Basic)
74.72M 63.1M
Shares Outstanding (Diluted)
74.72M 63.1M
EPS (Basic)
-1.52 -1.81
EPS (Diluted)
-1.52 -1.81
EBITDA
-124.69M -115.58M
EBIT
-125.92M -115.58M
Depreciation & Amortization
3.47M 387K